| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/26/2007 | EP1302461B1 Tnf-alpha production inhibitors |
| 09/26/2007 | EP1261585B1 Substituted indole mannich bases |
| 09/26/2007 | EP1228046B1 Phthalazinone derivatives as pde 4 inhibitors |
| 09/26/2007 | EP1198250B1 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 09/26/2007 | EP1035865B1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/26/2007 | EP0787191B1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 09/26/2007 | CN101044120A Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 09/26/2007 | CN101043900A 肽混合物 Peptide mixture |
| 09/26/2007 | CN101041629A New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it |
| 09/26/2007 | CN101041067A Preparation for beauty and for adjusting the immunity |
| 09/26/2007 | CN101040991A Chinese traditional medicine compound took orally for treating lupus erythematosus |
| 09/26/2007 | CN101040962A Chinese traditional medicine compound took orally for treating urticaria |
| 09/26/2007 | CN101040958A Medical function of fresh rehmannia root juice for treating and preventing allergic diseases |
| 09/26/2007 | CN101040938A Ganoerma lucidum anti-inflammatory detumescent compound agent |
| 09/26/2007 | CN101040928A Treatment type ganoerma lucidum compound tea |
| 09/26/2007 | CN101040921A Immunopotentiator of trepang compound Chinese traditional medicine |
| 09/26/2007 | CN101040912A Chinese traditional medicine capsule preparation for resisting radiation and improving immunity and the method for preparing the same |
| 09/26/2007 | CN101040895A Medicine for improving immunity |
| 09/26/2007 | CN101040869A Nanometer elemental selenium coupled with liquid amino acid and the method for preparing and preserving the same |
| 09/26/2007 | CN101040848A Method for preparing amphiphilic nanoparticles |
| 09/26/2007 | CN101040713A Health-care food having functions of oxidation resisting and immunity improving |
| 09/26/2007 | CN101040709A 保健食品 Health Food |
| 09/26/2007 | CN101040650A Health-care type ganoderma lucidum combined tea |
| 09/26/2007 | CN100339387C Method for preparing antler polypeptide and medicine with the antler polypeptide as main active component |
| 09/26/2007 | CN100339130C 疫苗 Vaccine |
| 09/26/2007 | CN100339081C Oral loratadine disintegrating tablet and its prepn |
| 09/25/2007 | US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/25/2007 | US7273875 Blocking tumor necrosis factor; antiinflammatory agents; respiratory system disorders; bronchodilator |
| 09/25/2007 | US7273872 alpha 7 receptor is the alpha -bungarotoxin sensitive receptor that influences the release of proinflammatory cytokines from macrophages |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | US7273852 Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases |
| 09/25/2007 | US7273752 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 09/25/2007 | US7273751 Comprises nucleotide sequences associated with expression vector coding endothelial growth factor for use in diagnosis and treatment of tumor angiogenesis, inflammation, diabetic retinopathy, arthritis and psoriasis; wound healing agent |
| 09/25/2007 | US7273744 Heparanase-like polypeptides |
| 09/25/2007 | US7273613 Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders |
| 09/25/2007 | US7273609 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
| 09/25/2007 | CA2547947C Azole derivatives as active superoxide radical inhibitors |
| 09/25/2007 | CA2511753C Phospholipid derivatives |
| 09/25/2007 | CA2364446C Novel immunosuppressive agent |
| 09/25/2007 | CA2294649C Bovine adenovirus type 3 genome |
| 09/25/2007 | CA2200967C Pharmaceutical compositions |
| 09/25/2007 | CA2173592C Stem cell proliferation factor |
| 09/24/2007 | CA2571933A1 A descarbonylethoxyloratadine containing pharmaceutical composition |
| 09/20/2007 | WO2007106056A1 Compositions and methods for treating t-cell mediated pathological conditions |
| 09/20/2007 | WO2007105945A2 Use of non-digestable sacharides for giving an infant the best start after birth |
| 09/20/2007 | WO2007105910A1 A pharmaceutical composition for the treatment of allergic diseases and chronic inflammatory diseases, and a method for treatment of allergic diseases and chronic inflammatory diseases |
| 09/20/2007 | WO2007105797A1 Novel human t cell population |
| 09/20/2007 | WO2007105766A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/20/2007 | WO2007105637A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | WO2007104790A1 Autoimmune conditions and nadph oxidase defects |
| 09/20/2007 | WO2007104581A1 Use of recombinant modified vaccinia virus ankara (mva) for the treatment of type 1 hypersensitivity in a living animal including humans |
| 09/20/2007 | WO2007104493A1 Use for vasoactive intestinal peptide (vip) and the isolated cells stimulated by said peptide |
| 09/20/2007 | WO2007104143A1 METHODS FOR DIAGNOSIS AND PROGNOSIS OF GRAFT VERSUS HOST DISEASE BY MEASUREMENT OF PERIPHERAL CD3+CD4+CD8β+ CELLS |
| 09/20/2007 | WO2007104070A1 Method and composition for treating allergic diseases |
| 09/20/2007 | WO2007082715A3 Anti-cd19 antibody composition and method |
| 09/20/2007 | WO2007048122A3 Antibody-based therapeutics with enhanced adcc activity |
| 09/20/2007 | WO2007041513A3 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 09/20/2007 | WO2006082098A8 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof |
| 09/20/2007 | US20070219264 inhibiting rejection of a transplanted organ, tissue or cell in a recipient mammal; immunosuppressive agent; autoimmune diseases |
| 09/20/2007 | US20070219232 Chemical Compounds |
| 09/20/2007 | US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both |
| 09/20/2007 | US20070219202 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 09/20/2007 | US20070219197 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives |
| 09/20/2007 | US20070219194 Phenylalanine derivatives |
| 09/20/2007 | US20070219128 Medical and health-care uses of pufferfish type I collagen extract and processes for producing said extract |
| 09/20/2007 | US20070218523 Modified human thymic stromal lymphopoietin |
| 09/20/2007 | US20070218077 Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response |
| 09/20/2007 | US20070218073 Antigenic composition |
| 09/20/2007 | US20070218070 Methods of modulation of the immune system |
| 09/20/2007 | US20070218067 useful for monitoring the (de)activation status if the patient is treated with thrombocyte aggregation inhibitors |
| 09/20/2007 | US20070218033 Composition and method of treating hepatitis C |
| 09/20/2007 | DE4003844B4 Neue Cyclosporin enthaltende galenische Formulierungen New cyclosporin-containing pharmaceutical formulations |
| 09/20/2007 | CA2645472A1 Use of non-digestable saccharides for giving an infant the best start after birth |
| 09/20/2007 | CA2644368A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | CA2643580A1 Specific cd4+cd25+ regulatory t cells for haematopoietic cell transplantation and immune tolerance |
| 09/20/2007 | CA2643070A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/19/2007 | EP1835031A1 Use of a recombinant modified vaccinia virus Ankara (MVA) for the treatment of type I hypersensitivity in a living animal including humans |
| 09/19/2007 | EP1835027A1 Novel cancer antigen peptide and the use thereof |
| 09/19/2007 | EP1835021A1 Novel strain conferring anti-disease properties to host and bacterial cell composition |
| 09/19/2007 | EP1834961A2 Design of chemokine analogs for the treatment of human diseases |
| 09/19/2007 | EP1834960A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/19/2007 | EP1834959A2 Tert-butyl-substituted aromatic steroids having cytoprotective activity |
| 09/19/2007 | EP1834947A2 3-substituted amino-1H-indole-2-carboxylic acid and 3-substituted amino-benzo[B]thiophene-2carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 09/19/2007 | EP1834671A2 A method for generation of antibodies to cell surface molecules |
| 09/19/2007 | EP1833991A2 Trefoil factors and methods of treating proliferation disorders using same |
| 09/19/2007 | EP1833964A1 Regulation of metalloprotease cleavage of cell surface proteins |
| 09/19/2007 | EP1833836A1 Imidazo-fused thiazolo [4,5-b] pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 09/19/2007 | EP1833812A1 N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl]amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid cb1 receptor antagonists |
| 09/19/2007 | EP1833791A2 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists |
| 09/19/2007 | EP1622867B1 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 09/19/2007 | EP1499605B1 NF-KappaB INHIBITORS |
| 09/19/2007 | EP1496907B1 Tyrosine kinase inhibitors |
| 09/19/2007 | EP1407044B1 Rna interference mediating small rna molecules |
| 09/19/2007 | EP1326990B1 Packaging of positive-strand rna virus replicon particles |
| 09/19/2007 | EP1309590B1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 09/19/2007 | EP1255844B1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 09/19/2007 | CN101039960A Chimeric and humanised monoclonal antibodies against interleukin-13 |
| 09/19/2007 | CN101039953A Therapeutic and diagnostic agents |
| 09/19/2007 | CN101039933A Diaminotriazole compounds useful as protein kinase inhibitors |
| 09/19/2007 | CN101039700A Vaccine conjugate including a human chorionic gonadotropin beta subunit antigen linked to an anti-mannose receptor (mr) antibody |